Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Request metadata listed "Encompass Health Corp," but the filing text identifies the registrant as HealthSouth Corporation).
Filing Type: Form 10-Q (Unaudited Quarterly Report).
Period Ended: March 31, 2006.
Business Overview: HealthSouth is a major provider of rehabilitative health care, ambulatory surgery, and diagnostic imaging services in the United States, operating through inpatient and outpatient rehabilitation facilities, surgery centers, and diagnostic centers. The company is in a turnaround phase following significant financial restatements and legal settlements.
Key Financial Metrics
| Metric | Q1 2006 | Q1 2005 |
|---|---|---|
| Net Operating Revenues | $791.99 million | $848.60 million |
| Net Loss | $(435.14) million | $(258.20) million |
| Loss Per Share (Basic & Diluted) | $(1.09) | $(0.65) |
| Operating Cash Flow | $(71.31) million (Used) | $16.57 million (Provided) |
| Total Assets | $3,456.96 million | $3,592.21 million |
| Total Liabilities | $4,753.78 million | $4,859.19 million |
| Shareholders' Deficit | $(1,971.98) million | $(1,540.72) million |
| Cash and Cash Equivalents | $137.29 million | $175.50 million |
Adjusted Consolidated EBITDA: $137.15 million for Q1 2006, down from $204.89 million in Q1 2005.
Material Changes vs. Prior Period
- Revenue Decline: Net operating revenues decreased 6.7% year-over-year, primarily due to volume decreases in the inpatient segment (driven by the 75% Rule phase-in) and surgery centers (due to closures and competition).
- Increased Net Loss: The net loss increased by 68.5% to $435.14 million. This was significantly impacted by a $361.1 million loss on early extinguishment of debt resulting from recapitalization transactions.
- Recapitalization: On March 10, 2006, the company completed a major recapitalization, replacing approximately $3 billion of prior indebtedness with new long-term debt and issuing $400 million of convertible perpetual preferred stock.
- Settlement Expenses: Government, class action, and related settlements expense dropped to $0.13 million in Q1 2006 from $215.0 million in Q1 2005 (the prior year charge related to a preliminary securities litigation settlement).
- Discontinued Operations: The company reported a loss from discontinued operations of $12.85 million, compared to $17.82 million in the prior year, largely due to the sale of the Birmingham Medical Center which resulted in a $7.3 million net loss on disposal.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
Management anticipates continued price pressure from government and commercial payors and expects the 75% Rule to continue negatively impacting inpatient volumes throughout 2006. The company is focusing on operational efficiency, expense control, and stabilizing its ambulatory divisions. While the recapitalization improved the capital structure and reduced near-term refinancing risk, the company remains highly leveraged.
Unusual Items
- Debt Extinguishment: A one-time charge of $361.1 million related to the prepayment of prior debt.
- Accounting Change: Adoption of FASB Statement No. 123(R) on January 1, 2006, increased stock-based compensation expense by approximately $2.7 million.
- Asset Sale Loss: A $7.3 million loss on the sale of the Birmingham Medical Center, driven largely by $29 million in lease termination costs.
Risks and Contingencies
- Litigation: Significant ongoing legal proceedings include securities class actions (preliminary settlement reached for $215 million in stock/warrants plus $230 million from insurance), derivative litigation, and disputes with former CEO Richard Scrushy. Final court approval of settlements is not guaranteed.
- Regulatory: Continued investigations by the Department of Justice and other agencies regarding financial reporting and Medicare billing practices.
- Liquidity: The company has significant cash obligations for government settlements ($149.4 million remaining on Medicare settlement; $87.5 million remaining on SEC settlement) due through 2007.
- Internal Controls: Management concluded that disclosure controls and procedures were ineffective as of March 31, 2006, due to material weaknesses existing since the prior year-end.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new Credit Agreement's leverage ratio (7.25 to 1.00) and interest coverage ratio (1.65 to 1.00) covenants.
- Settlement Finality: Monitor court approval status of the $445 million preliminary securities litigation settlement and the $230 million insurance carrier contribution.
- Refinancing Timeline: Confirm the company's ability to refinance the $1 billion interim loan (maturing March 2007) with high-yield debt as planned in Q2 or Q3 2006.
- Volume Trends: Track inpatient discharge volumes and the impact of the 75% Rule on revenue stability.
- Internal Control Remediation: Review progress reports on remediation of material weaknesses in internal controls over financial reporting.